Trecadrine

Trecadrine ( ) is a drug that was originally developed as an anti-ulcer agent but was found to act as a β 3 -adrenergic receptor agonist with potential anti-obesity and anti-diabetic properties.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Trecadrine ( ) is a drug that was originally developed as an anti-ulcer agent but was found to act as a β 3 -adrenergic receptor agonist with potential anti-obesity and anti-diabetic properties. It is selective for the β 3 -adrenergic receptor, lacking activity at the β 1 - and β 2 -adrenergic receptors. The drug is orally active.

Structurally, trecadrine is a substituted β-hydroxyamphetamine and derivative of β-hydroxy-N-methylamphetamine (ephedrine, pseudoephedrine) with a tricyclic moiety attached at the amine.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1328680103 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.